420 with CNW – Four Easy Steps to Getting Your Arizona Medical Marijuana Card in 2019

In 2013, Phoenix New Times published an article showing people the step by step process of getting their Arizona Medical Marijuana Card. After August 27 of 2019, a new law signed by Governor Doug of Arizona allows patients, caregivers and pharmacy agents to access the medical marijuana card at half the cost. The card gives them the privilege of obtaining medical marijuana for two years instead of one.

The card is accessible by almost every resident of Arizona; therefore, if you are a marijuana consumer, make it a priority to get one of these out-of-jail free cards. Marijuana possession and consumption remains a felony for those who are not patients. Possession of marijuana products is classified as a class four crime, and it is likened to heroin possession and weapons misconduct.

This article gives you a step-by-step guide of the exact processes you need to follow to get your Arizona medical marijuana card.

Find out the Qualifying Conditions

To qualify for the medical cannabis card, you need to have one or more of the following ailments: ALS, Alzheimer’s disease, cancer, chronic pain, cachexia, Crohn’s disease, HIV/AIDS, epilepsy, multiple sclerosis, post-traumatic stress disorder, seizures, or severe nausea. Most of the patients qualifying for the medical card complain of chronic pain together with other ailments, or on its own.

Find a Qualified Medical Marijuana Doctor

Having qualifying conditions is not enough; you still need to find a qualified medical marijuana evaluator to give you a recommendation. You can find MMJ (medical marijuana) evaluators online or in newspapers. The MMJ doctor can be a naturopath, an osteopath or homoeopath who is registered in Arizona. A single visit will cost you $75-$150. If there are no qualifying conditions in your record, the MMJ doctor will refer you to another doctor. The designated doctor, for an additional fee, will provide you with an official diagnosis. People suffering from menstrual cramps and soreness from old injury also qualify for the Arizona medical cannabis card.

Submit Your Application

The Arizonian Department of Health Services (DHS) provides guidelines on the process of submitting applications. You can visit the site https://azdhs.gov/licensing/medical-marijuana/index.php. In earlier days, people used to submit their applications, but in recent times the doctors upload your photo and documentation to the DHS system. As the applicant, you will have to sign a form promising not to sell or misuse your medication. The application will cost you $150, but if you qualify for food assistance, you will only pay $75. If you are issued with the new MMJ card, you will have access to medical marijuana for two years.

Get Your Medical Marijuana

After you have received your medical marijuana card, you can start enjoying the benefits of weed by purchasing from a certified pharmacy near you. You are allowed to buy up to 2.5 ounces of medical cannabis every two weeks. If you live 25 miles or farther from the nearest dispensary, you are allowed to grow a few medical marijuana plants.

A court ruling passed in 2019 prohibits patients from smoking weed in public or a car in a public parking space. The patients should also keep medical marijuana from children.

Possession of the Arizona medical card provides defense against prosecution, but it does not erase state laws governing marijuana. Therefore patients should abide by the rules because breaking them lands you in felony territory. In Arizona, more than 200,000 patients are enjoying the benefits of medical marijuana without fear of being arrested.

Analysts expect the entire marijuana industry, including VIVO Cannabis Inc. (CSE: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB), to applaud the fact that Arizona patients now no longer have to go through the hassles of getting a new card each year.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canberra Becomes the First City to Legalize Recreational Marijuana in Australia

Following a landmark vote on Tuesday, Canberra becomes the first city to legalize recreational marijuana in Australia. The passed bill allows individuals who are 18 years plus to legally possess, use and cultivate small amounts of weed for recreational use.

The ABC state broadcaster reported that the new law would be implemented as from the last day of January next year. The new law stipulates that Canberra residents can legally possess up to 1.76 ounces of dried weed and cultivate a maximum of two or four plants per person or household, respectively.

Although the Australian government does not support the legalization of marijuana for personal use, Canberra becomes first in Australia’s six states such as Victoria, South Wales, and two territories; Northern Territory and Southern Australia to legalize recreational marijuana.

In Australia, drug laws differ on a state by state basis. The current ACT law stipulates that a person cultivating marijuana plants or in possession of 1.76 ounces of dried marijuana will attract a fine of $108 while those possessing more than 1.76 ounces will attract a two-year sentence or a fine of 8000 Australian dollars.

Marijuana is one of the primary drugs that is highly abused in Australia. In the financial year 2017-2018, cannabis-related arrest were 72,000, of which 92% of these comprised of cannabis consumers.

Conflicting with the national drug laws is the ACT’s new law allowing people to possess marijuana. ACT’s law which was passed by ten votes, states that driving with detectable levels of marijuana is a prosecutable offense. It is not the first time for the federal laws to conflict with the ACT’s laws. In 2013, same-sex marriage was legalized by the ACT, but the High Court of Australia cancelled the bill citing that it was inconsistent with the federal law.

Times are changing, and the Australian parliament is not left behind. In 2016, it approved the first bill in Australia, allowing people to grow marijuana legally for medical and research purposes.

New Zealand, a country which neighbors Australia, has legalized the used of medical cannabis. However, recreational marijuana is prohibited in New Zealand. The country plans on holding a referendum to legalize marijuana for personal use in 2020. If New Zealand is successful in legalizing Marijuana for recreational purposes, it will be the third country on the globe.

In the United States, nearly a dozen states, including Washington, D.C., permit the use of recreational marijuana. Additionally, many parts of Europe have decriminalized recreational marijuana.

Industry experts think that whenever marijuana companies like Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) see news of marijuana reforms in other jurisdictions, they wonder when the U.S. federak government will take the cue and reform its own outdated marijuana laws.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Plans to Expand Reach of Distinctive 100% Natural CBD Oil

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) manufactures 100% natural CBD oil using the supercritical CO2 liquid extraction, isolation and micron-filtration process. An article discussing the company reads, “ETST recently filed a 10-K annual report with the SEC that included an outline of the company’s five-year expansion plan for manufacturing and marketing its CBD products (http://cnw.fm/z6FOm). The plan includes information about the company’s strategic preparations to scale up the production of its CBD oil, introduce new products and make its innovative hemp products available worldwide (http://cnw.fm/7gI5w). . . . ‘Our CBD-rich hemp oil does not contain any synthetic cannabinoids and is not an isolate,’ the SEC report noted. ‘It contains everything that is naturally occurring in the original industrial-hemp plant. With our high-quality, CBD-rich hemp oil, you benefit from the natural interaction of phytonutrients in their balanced, wide-ranging form that may offer the most benefit for overall wellness.’ The report further noted that the company’s ‘commercialized, CBD-based product line, High-Grade Full Spectrum Cannabinoids, offers seven distinct cannabinoids maximizing all the therapeutic benefits the industrial-hemp plant has to offer.’”

To view the full article, visit http://cnw.fm/Jbr5M

About Earth Science Tech Inc.

Earth Science Tech offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. ETST notes positive results in studies on breast cancer and immune cells conducted through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the company’s CBD-oil formulation lowers cortisol and functions as a neuroprotectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most-effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDNewsBreaks – Neutra Corp. (NTRR) Targets Hemp-Based CBD Market

Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, is aiming to participate in the hemp-based CBD market through its recent strategic acquisition of Vivis Corp. A recent article discussing the interview reads, “The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49%, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://cnw.fm/6MJmx). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries. . . . Neutra Corp.’s previously announced acquisition of Vivis Corp., an emerging retail brand of hemp-based health and nutritional products, is a natural fit for the company. All Vivis CBD products are third-party tested and certified, assuring the consumer that its hemp-derived CBD products are contaminant free and of a consistently high purity (http://cnw.fm/ye4RM).”

To view the full article, visit http://cnw.fm/0LLnw

About Neutra Corp.

Neutra Corp. is an early-stage research and development company committed to bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the new, thriving, hemp-based CBD market, in which the company intends to participate. For more information, visit the company’s website at www.Neutrainc.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Temporarily Suspends Production in California Amid Vape Product Safety Concerns

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) this morning provided an update addressing the recent vaporizer product safety concerns. In the release, IONKF reiterated its concentration on safety and its commitment to self-regulating above and beyond required regulations and quality measures. In light of the recent vaping events, and in response to the company’s concern with illegal and unregulated black-market products in California, IONKF has temporarily suspended production in California until regulators can address the issue. “This is a situation that we take seriously and are monitoring closely,” IONIC Brands CEO and chairman John Gorst stated in the news release.

To view the full press release, visit http://cnw.fm/R4ntV

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – VPR Brands LP (VPRB) to Debut Premier GOLDLINE CBD Products at NACS 2019

VPR Brands (OTCQB: VPRB), a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”), this morning announced that it will be debuting its premium GOLDLINE Hemp-Derived CBD products at the NACS Show 2019 taking place in Atlanta at the Georgia World Congress Center, October 2-4. The company will be located at booth #C5865 in the Hemp-Derived CBD Pavilion. “Our convenience store display program has started to pick up steam and is doing exceptionally well in the 34- to 54-year-old demographic, as our brand appeals to a more mature, affluent customer versus some of our competitors,” VPR Brands CEO Kevin Frija stated in the news release. “The hemp-derived CBD product category has been growing rapidly within the convenience store market over the past year, and we expect the trend to continue and our products to gain shelf space in store. The NACS show is the perfect trade event to showcase GOLDLINE CBD to convenience store retailers.”

To view the full press release, visit http://cnw.fm/R3tP8

About VPR Brands LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical-marijuana vaporizers and electronic-cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes, also known as e-cigarettes, are devices that deliver nicotine and/or cannabis through atomization or vaping without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Chief Marketing Officer Recognized on Forbes CMO Next List

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that Jann Parish, Chief Marketing Officer, has been named to the Forbes CMO Next list, a list comprised of 50 individuals considered to be leading the way as disruptive chief marketers. Established through qualitative research and editorial industry knowledge, the Forbes list features executives in the top marketing position at their company that push brand and business growth. Through Parish’s leadership the company has opened over 130 Seventh Sense CBD shops, expanded Seventh Sense’s digital reach, increased sales and margin figures in its Nevada The+Source dispensary business by double digits and prepared for the October launch of a new CBD brand, Green Lily. “I am honored and humbled to receive this recognition,” Green Growth Brands CMO Jann Parish stated in the news release. “I am thrilled to be applying my expertise to the cannabis and CBD industries. At Green Growth Brands, we look at this moment in time as an opportunity to reinvent the way consumers view and interact with products that have very complicated histories. For Forbes to be considering our industry as part of this award speaks to the progress we have already made.”

To view the full press release, visit http://cnw.fm/Y0kkr

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S. its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – UK Experts Want Medical Marijuana Free for All

The UK government has legalized the use of medical marijuana; however, accessing it is next to impossible. This has prompted professors, doctors, health experts, and politicians to sign letters petitioning the government to make medical marijuana free to all patients. To access medical marijuana for free, patients have to present a prescription from the NHS (National Health Service), which serves as the United Kingdom’s comprehensive, universal, and free-at-the-point-of-service system of medication.

It is legal to prescribe medical cannabis under particular conditions on the NHS system; however, there exist several restrictions and obstacles that hinder specialists from prescribing medical marijuana treatment to patients. The letter signed by the pharmacists, health experts, and members of parliament appeals to the UK Health Secretary Matt Hancock to lift these restrictions. The Members of Parliament representing the Liberal Democrats and Labour have also signed a letter to the Prime Minister, Boris Johnson, appealing to him to intervene for the patients who are unable to access medical marijuana prescriptions.

Doctors and politicians are ready to change the highly restrictive measures administered by the UK government regarding legal access to medical cannabis. The UK government system governing access to medical marijuana does not give access to those patients who highly need it, thus causing unnecessary deaths and addiction to painkillers which could be avoided by treating the patient with medical cannabis.

In their letter to Mr. Hancock, the health experts argue that the failure of the medical and pharmacy professions to embrace medical cannabis is the leading cause of death from conditions that could be prevented, such as epilepsy.

A recent study by Public Health England concludes that a quarter of the population, ‘mainly adults’ consume strong painkillers, sleeping aids and antidepressants. The conditions forcing them to take these medications could be effectively and safely treated using medical marijuana.

Health experts in the UK want these restrictions lifted because it would make it easier for the doctors to prescribe medical cannabis for treatment using the NHS system. They want Hancock to scrape off the rule requiring a senior doctor to sign off on a prescription and allow a general specialist to write medical marijuana prescriptions. Besides, they want the laws governing the importation of medical marijuana simplified.

The proposed changes to medical marijuana could improve the lives of many patients because with a prescription from the medical provider; patients can access medical cannabis freely. Lack of access to medical cannabis prescription forces patients to seek the help of private caregivers who are very expensive; forcing the patients to turn to the use of unregulated weed for relief.

For the long term effect of free medical marijuana to be seen, professors, health experts and MPs advocate for the training of doctors on medical cannabis treatment and the process of prescribing. Medical cannabis should be prescribed to patients suffering from chronic pain, epilepsy, cancer, multiple sclerosis, depression and insomnia.

In response to the letter, NICE (National Institute for Health and Care Excellence) is opposed to the use of medical marijuana, citing lack of enough clinical evidence.

Industry analysts think that marijuana industry actors like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) would wish that UK patients get as much access to Medical marijuana as those in Northern America.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New York, New Jersey and Connecticut Governors to Discuss Harmonizing Marijuana Legalization Laws

On Tuesday, Andrew Cuomo, the New York Governor said that he plans to have a meet up with Connecticut and New Jersey Governors to discuss how they can come up with a joint program that ensures consistency as they move forward with the legalization of recreational marijuana.

In a radio interview on Long Island, New York Governor, Andrew Cuomo said that his intention for the meeting is to discuss the possibilities of having regional laws on vaping products and weed. He also added that it would make no sense for the three states to have different marijuana policies, because, this would only force people to drive across the border to the neighboring states be it Jersey or Connecticut and buy cannabis.

New York is serious about marijuana legalization; therefore, the process of recreational marijuana legalization has to be right and protected, said the New York Governor during the interview. He added that he intended to start the talks with the Connecticut Governor Lamont, to see if he is open to sharing the same policy, as it would be counterproductive to have separate policies because Marijuana consumers would drive to the neighboring states to buy weed of better or poorer quality, have more THC, and eventually, you have people vaping and smoking marijuana while driving.

The interview also covered the issue of introducing regulation that prohibits youth from consuming marijuana. Products that appeal to the youth and contain cannabis should be banned. These products include weed flavored gummy bears and cigarettes containing cannabis.

When recreational marijuana is legalized, Mr. Cuomo also plans to ban the smoking of weed, a policy he supported when medical marijuana was legalized in New York in the year 2014. The New York governor intends on talking about the possibilities of adding these bans in the shared policy. If Connecticut and New Jersey do not adopt these bans, it will make no sense introducing them in New York as people would cross the border to buy weed.

In an interview with WNYC, Governor Cuomo said that it is the responsibility of the state to come up with rules as there are no federal regulations governing marijuana reforms. He added that their discussions would include the limit of THC, the age at which individuals should consume recreational marijuana, the process of preparing weed for consumption, and the volume of sales. The meeting aims to arrive at a common goal.

The New York Governor Andrew Cuomo and Connecticut Governor Lamont went on a fishing trip last month where they discussed issues of interest in the two states, such as cybercrime, transportation and marijuana legalization.

The three states did not manage to have recreational marijuana legalized this year. However, they are optimistic about the coming year. New York plans to make the legalization of recreational marijuana a major priority in the year 2020 legislative sessions. While in New Jersey, the lawmakers suggest advancing the issue of recreational marijuana legalization for the voter decision through a referendum in 2020.

Experts believe that marijuana industry actors like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and Sugarmade Inc. (OTCQB: SGMD) would be happy if the three states managed to pass similar marijuana laws since this would remove a lot of uncertainty for the users who frequently cross into these states.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Jushi Holdings Inc.’s (NEO: JUSH.B) (OTCQX: JUSHF) BEYOND / HELLO(TM) Retail Chain Opens Two New Medical Marijuana Dispensaries in Pennsylvania

BEYOND / HELLO(TM), a premier retail chain owned by Jushi Holdings (NEO: JUSH.B) (OTCQX: JUSHF), recently announced the opening of two new retail locations. The dispensaries, located in Scranton and Johnstown, PA, opened after receiving approval from the Pennsylvania Department of Health. The stores will carry an assortment of medical marijuana products including dry leaf, oils and oil cartridges, concentrates, pills, capsules, tinctures, topicals and many ancillary products. Each location will have a team of experienced staff as well as a licensed pharmacist on-site to dispense products, answer questions and provide service to patients and caregivers. “As we strategically expand our footprint across the Commonwealth, our goal is to bring more patients access to state-approved medicinal treatments that work for them,” BEYOND / HELLO President Blythe Huestis stated in the news release. “With the opening of our Scranton and Johnstown locations, we are providing patients and caregivers increased access to some of the best medicinal treatments and professional expertise available. In addition, these openings will create roughly 50 new, livable-wage jobs in the communities they serve.”

To view the full press release, visit http://cnw.fm/IpE0H

About Jushi Holdings Inc.

Jushi Holdings is a globally-focused cannabis and hemp company led by an industry leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed work-outs and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information, visit the company’s website at www.JushiCo.com.

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com